• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胎盘微小RNA表达不受母体肥胖和胎儿过度生长的影响。

Placental microRNA Expression Is Not Altered by Maternal Obesity and Fetal Overgrowth.

作者信息

Ghaffari Neda, Parry Samuel, Elovitz Michal A, Durnwald Celeste P

机构信息

Department of Obstetrics and Gynecology, Center for Research on Reproduction and Women's Health, Maternal and Child Health Research Program, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania.

出版信息

AJP Rep. 2016 Oct;6(4):e430-e435. doi: 10.1055/s-0036-1597652.

DOI:10.1055/s-0036-1597652
PMID:28050331
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5201431/
Abstract

The epigenetic mechanisms underlying fetal metabolic programming are poorly understood. We studied whether obesity is associated with alterations in placental miRNA expression.  A cross-sectional study was performed, including (1) normal-weight women (BMI 20-24.9 kg/m) and normal-birth-weight (BW) infants (2,700-3,500 g) ( = 20), (2) normal-weight and macrosomic infants (BW ≥ 4,000 g) ( = 10), (3) obese (BMI ≥ 35 kg/m) and normal BW infants ( = 16), and (4) obese and macrosomic infants ( = 10). All had term deliveries (37-41 weeks) and normal glucose tolerance (1 hour GCT < 7.2 mmol/L [130 mg/dL]). The expression of 5,639 placental miRNAs was assessed using miRNA microarray. Differential miRNA expression was determined using two-way ANOVA and pairwise contrasts, with the Benjamini-Hochberg (BH) correction. MiRNAs with Z-scores ≥ 2 and false discovery rate (FDR) < 20% were considered significant.  Principal components analysis demonstrated similar global miRNA expression profiles among groups. Of 5,639 miRNAs, only 5 were significantly different between obese and controls, which were not validated by quantitative polymerase reaction.  There was no difference in placental miRNA expression associated with obesity or overgrowth. Aberrant placental miRNA expression is an unlikely mechanism underlying fetal metabolic programming related to maternal obesity.

摘要

胎儿代谢编程背后的表观遗传机制目前仍知之甚少。我们研究了肥胖是否与胎盘微小RNA(miRNA)表达的改变有关。

我们进行了一项横断面研究,研究对象包括:(1)体重正常的女性(体重指数[BMI]为20 - 24.9 kg/m²)及出生体重正常(BW)的婴儿(2700 - 3500 g)(n = 20);(2)体重正常但婴儿为巨大儿(BW≥4000 g)(n = 10);(3)肥胖(BMI≥35 kg/m²)且婴儿出生体重正常(n = 16);以及(4)肥胖且婴儿为巨大儿(n = 10)。所有研究对象均为足月分娩(37 - 41周)且葡萄糖耐量正常(1小时血糖筛查试验[GCT] < 7.2 mmol/L [130 mg/dL])。使用miRNA微阵列评估了5639种胎盘miRNA的表达。采用双向方差分析和两两对比法确定miRNA的差异表达,并进行Benjamini - Hochberg(BH)校正。Z分数≥2且错误发现率(FDR)< 20%的miRNA被认为具有显著性差异。

主成分分析表明,各组之间的整体miRNA表达谱相似。在5639种miRNA中,肥胖组与对照组之间仅有5种存在显著差异,但未通过定量聚合酶反应验证。

与肥胖或胎儿过度生长相关的胎盘miRNA表达没有差异。胎盘miRNA表达异常不太可能是与母体肥胖相关的胎儿代谢编程的潜在机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f10d/5201431/b9ae9748ebd9/10-1055-s-0036-1597652-i160074-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f10d/5201431/b9ae9748ebd9/10-1055-s-0036-1597652-i160074-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f10d/5201431/b9ae9748ebd9/10-1055-s-0036-1597652-i160074-1.jpg

相似文献

1
Placental microRNA Expression Is Not Altered by Maternal Obesity and Fetal Overgrowth.胎盘微小RNA表达不受母体肥胖和胎儿过度生长的影响。
AJP Rep. 2016 Oct;6(4):e430-e435. doi: 10.1055/s-0036-1597652.
2
The Effect of an Obesogenic Maternal Environment on Expression of Fetal Umbilical Cord Blood miRNA.致肥胖的母体环境对胎儿脐带血miRNA表达的影响
Reprod Sci. 2015 Jul;22(7):860-4. doi: 10.1177/1933719114565032. Epub 2014 Dec 28.
3
[Factors relevant to newborn birth weight in pregnancy complicated with abnormal glucose metabolism].[妊娠合并糖代谢异常时与新生儿出生体重相关的因素]
Zhonghua Fu Chan Ke Za Zhi. 2010 Sep;45(9):646-51.
4
Pre-pregnancy body mass index (BMI) and macrosomia in a Canadian birth cohort.加拿大出生队列中的孕前体重指数(BMI)与巨大儿
J Matern Fetal Neonatal Med. 2017 Jan;30(1):109-116. doi: 10.3109/14767058.2016.1163679. Epub 2016 Apr 6.
5
Exercise prevents the adverse effects of maternal obesity on placental vascularization and fetal growth.运动可预防母体肥胖对胎盘血管化和胎儿生长的不良影响。
J Physiol. 2019 Jul;597(13):3333-3347. doi: 10.1113/JP277698. Epub 2019 May 28.
6
Gestational diabetes mellitus diagnosed at 24 to 28 weeks of gestation in older and obese Women: Is it too late?在年龄较大和肥胖的女性中,在 24 至 28 孕周诊断出妊娠糖尿病:为时已晚吗?
PLoS One. 2019 Dec 16;14(12):e0225955. doi: 10.1371/journal.pone.0225955. eCollection 2019.
7
Maternal body mass index impacts fetal-placental size at birth and umbilical cord oxygen values with implications for regulatory mechanisms.母体体重指数影响出生时胎儿-胎盘大小及脐带氧含量,对调节机制有影响。
Early Hum Dev. 2017 Sep;112:42-47. doi: 10.1016/j.earlhumdev.2017.06.009. Epub 2017 Jul 6.
8
Dysregulation of Placental miRNA in Maternal Obesity Is Associated With Pre- and Postnatal Growth.母体肥胖症中胎盘 miRNA 的失调与产前和产后生长有关。
J Clin Endocrinol Metab. 2017 Jul 1;102(7):2584-2594. doi: 10.1210/jc.2017-00089.
9
Choline prevents fetal overgrowth and normalizes placental fatty acid and glucose metabolism in a mouse model of maternal obesity.胆碱可预防胎儿过度生长,并使肥胖症母鼠模型的胎盘脂肪酸和葡萄糖代谢恢复正常。
J Nutr Biochem. 2017 Nov;49:80-88. doi: 10.1016/j.jnutbio.2017.08.004. Epub 2017 Aug 12.
10
The Effect of Maternal Obesity on Pregnancy Outcome in Correlation With Placental Pathology.母亲肥胖与胎盘病理相关对妊娠结局的影响。
Reprod Sci. 2015 Dec;22(12):1643-8. doi: 10.1177/1933719115592712. Epub 2015 Jun 30.

引用本文的文献

1
Maternal obesity alters C19MC microRNAs expression profile in fetal umbilical cord blood.孕妇肥胖会改变胎儿脐带血中C19MC微小RNA的表达谱。
Nutr Metab (Lond). 2020 Jul 6;17:52. doi: 10.1186/s12986-020-00475-7. eCollection 2020.

本文引用的文献

1
The Effect of an Obesogenic Maternal Environment on Expression of Fetal Umbilical Cord Blood miRNA.致肥胖的母体环境对胎儿脐带血miRNA表达的影响
Reprod Sci. 2015 Jul;22(7):860-4. doi: 10.1177/1933719114565032. Epub 2014 Dec 28.
2
Prevention, management, and outcomes of macrosomia: a systematic review of literature and meta-analysis.巨大儿的预防、管理和结局:文献系统评价和荟萃分析。
Obstet Gynecol Surv. 2013 Oct;68(10):702-9. doi: 10.1097/01.ogx.0000435370.74455.a8.
3
MicroRNA-210 contributes to preeclampsia by downregulating potassium channel modulatory factor 1.
微小RNA-210通过下调钾通道调节因子1促成子痫前期。
Hypertension. 2014 Oct;64(4):839-45. doi: 10.1161/HYPERTENSIONAHA.114.03530. Epub 2014 Jun 30.
4
Environmental exposures in utero and microRNA.子宫内的环境暴露与微小RNA
Curr Opin Pediatr. 2014 Apr;26(2):243-51. doi: 10.1097/MOP.0000000000000073.
5
Optimising sample collection for placental research.优化胎盘研究的样本采集
Placenta. 2014 Jan;35(1):9-22. doi: 10.1016/j.placenta.2013.11.005. Epub 2013 Nov 19.
6
Identification and comparative analyses of myocardial miRNAs involved in the fetal response to maternal obesity.鉴定和比较分析与胎儿对母体肥胖反应相关的心肌 microRNAs。
Physiol Genomics. 2013 Oct 1;45(19):889-900. doi: 10.1152/physiolgenomics.00050.2013. Epub 2013 Aug 6.
7
Differentially expressed genes in the pre-eclamptic placenta: a systematic review and meta-analysis.子痫前期胎盘差异表达基因的系统评价和荟萃分析。
PLoS One. 2013 Jul 12;8(7):e68991. doi: 10.1371/journal.pone.0068991. Print 2013.
8
Differential effects of maternal obesity and weight loss in the periconceptional period on the epigenetic regulation of hepatic insulin-signaling pathways in the offspring.母体肥胖和孕期体重减轻对后代肝脏胰岛素信号通路表观遗传调控的差异影响。
FASEB J. 2013 Sep;27(9):3786-96. doi: 10.1096/fj.13-227918. Epub 2013 May 31.
9
Screening tests for gestational diabetes: a systematic review for the U.S. Preventive Services Task Force.妊娠期糖尿病筛查:美国预防服务工作组的系统评价。
Ann Intern Med. 2013 Jul 16;159(2):115-22. doi: 10.7326/0003-4819-159-2-201307160-00657.
10
Diagnostic potential for miRNAs as biomarkers for pregnancy-specific diseases.miRNAs 作为妊娠特有疾病生物标志物的诊断潜力。
Clin Biochem. 2013 Jul;46(10-11):953-60. doi: 10.1016/j.clinbiochem.2013.01.026. Epub 2013 Feb 7.